A stitch in time: 3-monthly long-acting injectable paliperidone palmitate in schizophrenia

被引：6
|
作者：
Taylor, Mark [1 ]
Huang, Hannah Chu-Han [2 ]
机构：
[1] Univ Queensland, Inala Mental Hlth, 64 Wirraway Pde, Brisbane, Qld 4077, Australia
[2] South London & Maudsley Trust, London, England
来源：
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY | 2017年 / 7卷 / 10期
关键词：
INJECTIONS;
D O I：
10.1177/2045125317721874
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：231 / 233
页数：3
相关论文
共 50 条
  • [31] Onset and persistence of efficacy by symptom domain with long-acting injectable paliperidone palmitate in patients with schizophrenia
    Alphs, Larry
    Bossie, Cynthia A.
    Fu, Dong-Jing
    Ma, Yi-Wen
    Sliwa, Jennifer Kern
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (07) : 1029 - 1042
  • [32] Early Australian experience in the maintenance of schizophrenia management with 3-monthly paliperidone palmitate
    Pai, Nagesh
    Warden, Matthew
    AUSTRALASIAN PSYCHIATRY, 2018, 26 (06) : 628 - 634
  • [33] BUDGET IMPACT ANALYSIS OF PALIPERIDONE PALMITATE 3-MONTHLY FOR THE TREATMENT OF SCHIZOPHRENIA IN ITALY
    Povero, M.
    Pradelli, L.
    VALUE IN HEALTH, 2017, 20 (09) : A710 - A710
  • [34] Angioedema Associated With Long-Acting Injectable Paliperidone Palmitate: A Case Report
    Papadopoulou, Athanasia
    Gkikas, Kitsos
    Efstathiou, Vasiliki
    Gkikas, Ilias
    Kokoris, Styliani
    Lagari, Vasiliki
    Papageorgiou, Charalabos
    Douzenis, Athanasios
    Siafakas, Nikolaos
    Rizos, Emmanouil N.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2017, 37 (06) : 730 - 732
  • [35] A case of tardive dystonia associated with long-acting injectable paliperidone palmitate
    Ma, Chia-Hao
    Chien, Yi-Ling
    Liu, Chen-Chung
    Chen, I-Ming
    Lin, Chia-Hsien
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 (07) : 1251 - 1252
  • [36] Use of paliperidone palmitate long-acting injectable in a patient with a personality disorder
    Martinez, N.
    Benitez Cerezo, E.
    Garcia Marin, S.
    EUROPEAN PSYCHIATRY, 2017, 41 : S714 - S714
  • [37] Onset of Efficacy of Long-acting Injectable Paliperidone Palmitate for Negative Symptoms and Anxiety/Depression in Subjects With Schizophrenia
    Fu, Dong-Jing
    Bossie, Cynthia A.
    Sliwa, Jennifer Kern
    Ma, Yi-Wen
    Alphs, Larry
    NEUROPSYCHOPHARMACOLOGY, 2013, 38 : S511 - S512
  • [38] Online Survey of Clinical Practice in Patients with Schizophrenia Treated with Long-Acting Injectable Aripiprazole or Paliperidone Palmitate
    Such, Pedro
    Olivares, Jose Manuel
    Arias, Lizbeth
    Berg, Mette Troels
    Madera, Jessica
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2021, 17 : 1881 - 1892
  • [39] Evaluation of paliperidone palmitate long-acting injectable antipsychotic therapy as an early treatment option in patients with schizophrenia
    Brown, Brianne
    Turkoz, Ibrahim
    Mancevski, Branislav
    Mathews, Maju
    EARLY INTERVENTION IN PSYCHIATRY, 2020, 14 (04) : 428 - 438
  • [40] Role of paliperidone palmitate 3-monthly in the management of schizophrenia: insights from clinical practice
    Lopez, Alicia
    Rey, Jose
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2019, 15 : 449 - 456
12345